Advertisement

Infection

, Volume 15, Issue 2, pp 133–141 | Cite as

Lipopolysaccharide, die Endotoxine und O-Antigene gramnegativer Bakterien: Chemische Struktur, biologische Wirkung und serologische Eigenschaften

  • E. Th. Rietschel
  • H. Brade
Therapie Und Prophylaxe Von Pseudomonas-Infektionen Teil II Symposium Vom 25. Bis 27. September 1986, Herrsching/Ammersee

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Westphal, O., Lüderitz, O., Galanos, C., Mayer, H., Rietschel, E. Th. The story of bacterial endotoxin. Adv. Immunopharmocol. In: (Chedid, L, Hadden, J. W., Ipreafico, F., Dukor, P., Willoghby, D. [eds.]) 3 (1986) pp. 13–34.Google Scholar
  2. 2.
    Lüderitz, O., Freudenberg, M. A., Galanos, C., Lehmann, V., Rietschel, E. Th., Shaw, D. H. Lipopolysaccharides of gram-negative bacteria. In:Razin, S., Rottem, S. (eds.): Membrane lipids of prokaryotes. Current topics in membranes and transport. Academic Press Inc., New York 1982, pp. 79–151.Google Scholar
  3. 3.
    Johnston, C. A., Greisman, S. E. Endotoxemia induced by antibiotic therapy: A mechanism for adrenal corticosteroid protection in gram-negative sepsis. Trans. Ass. Amer. Physcns. 97 (1984) 172–181.Google Scholar
  4. 4.
    Galanos, C., Lüderitz, O., Rietschel, E. Th., Westphal, O. Neweraspects of the chemistry and biology of bacterial lipopolysaccharides, with special reference to their lipid A component. In:Goodwin, T. W. (ed.): International review of biochemistry, Biochemistry of lipids II. University Park Press, Baltimore, Vol. 14, 1977, pp. 239–335.Google Scholar
  5. 5.
    Jann, K., Jann, B. Structure and biosynthesis of O-antigens. In:Proctor, R. A. (ed): Handbook of Endotoxin, Vol. I.Rietschel, E. Th. (ed.): Chemistry of Endotoxin. Elsevier, Amsterdam, New York, Oxford 1984, pp. 138–186.Google Scholar
  6. 6.
    Tacken, A., Rietschel, E. Th., Brade, H. Methylation analysis of the heptose / 3-deoxy-D-manno-2-octulosonic acid region (inner core) of lipopolysaccharide fromSalmonella minnesota rough mutants. Carb. Res. 149 (1986) 279–291.Google Scholar
  7. 7.
    Rietschel, E. Th., Wollenweber, H. W., Brade, H., Zähringer, U., Lindner, B., Seydel, U., Bradaczek, H., Barnickel, G., Labischinski, H., Giesbrecht, P. Structure and conformation of the lipid A component of lipopolysaccharides. in:Proctor, R. A. (ed.), Handbook of endotoxin, Vol. 1,Rietschel, E. Th. (ed.) Chemistry of endotoxin. Elsevier, Amsterdam, New York, Oxford 1984, pp. 187–220.Google Scholar
  8. 8.
    Zähringer, U., Lindner, B., Seydel, U. Rietschel, E. Th., Naoki, H., Unger, F. M., Imoto, M., Kusumoto, S., Shiba, T. Structure of de-O-acylated lipopolysaccharide from theEscherichia coli Re mutant F 515. Tetrahedron Lett. 26 (1985) 6321–6324.Google Scholar
  9. 9.
    Westphal, O., Lüderitz, O. Chemische Erforschung von Lipopolysacchariden gramnegativer Bakterien. Angew. Chem. 66 (1954) 407–417.Google Scholar
  10. 10.
    Imoto, M., Yoshimura, H., Sakaguchi, N., Kusumoto, S., Shiba, T. Total synthesis ofEscherichia coli lipid A. Tetrahedron Lett. 26 (1985) 1545–1548.Google Scholar
  11. 11.
    Galanos, C., Lüderitz, O., Rietschel, E. Th., Westphal, O., Brade, H., Brade, L., Freudenberg, M. A., Schade, U., Imoto, M., Yoshimura, H., Kusumoto, S., Shiba, T. Synthetic and naturalEscherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148 (1985) 1–5.Google Scholar
  12. 12.
    Kotani, S., Takada, H., Tsujimoto, M., Ogawa, T., Takahashi, I., Ideka, T., Otsuka, K., Shimanchi, H., Kasai, N., Mashimo, J., Nagao, S., Tanaka, S., Harada, K., Nagaki, K., Kitamura, H., Shiba, T., Kusumoto, S., Imoto, M., Yoshimura, H. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from anEscherichia coli Re-mutant. Infect. Immun. 49 (1985) 225–237.Google Scholar
  13. 13.
    Homma, J. Y., Matsuura, M., Kanegasaki, S., Kawakubo, Y., Kojima, Y., Shibukawa, N., Kumazawa, Y., Yamamoto, A., Tanamoto, K., Yasuda, T., Imoto, M., Yoshimura, H., Kusumoto, S., Shiba, T. Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J. Biochem. (Tokyo) 98 (1985) 395–406.Google Scholar
  14. 14.
    Loppnow, H., Brade, L., Brade, H., Rietschel, E. Th., Kusumoto, S., Shiba, T., Flad, H.-D. Lipid A-induced production of interleukin 1 in human monocytes. Eur. J. Immunol. 16 (1986) 1263–1267.Google Scholar
  15. 15.
    Rietschel, E. Th., Brade, H., Brade, L., Brandenburg, K., Schade, U., Seydel, U., Zähringer, U., Galanos, C., Lüderitz, O., Westphal, O., Labischinski, H., Kusumoto, S., Shiba, T. Lipid A, the endotoxic center of bacterial lipopolysaccharide: relation of chemical structure to biological activity. In:Watson, S. (ed.): 2nd International Conference on endotoxins and Their Detection with theLimulus amebocyte lysate. Alan R. Liss Inc., New York 1986 (im Druck).Google Scholar
  16. 16.
    Brandenburg, K., Seydel, U. Physical aspects of structure and function of membranes made from lipopolysaccharides and free lipid A. Biochem. Biophys. Acta 775 (1984) 225–238.Google Scholar
  17. 17.
    Labischinski, H., Barnickel, G., Bradaczek, H., Naumann, D., Rietschel, E. Th., Giesbrecht, P. High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J. Bacteriol. 162 (1985) 9–20.Google Scholar
  18. 18.
    Lindberg, A. A., Wollin, R., Bruse, C., Ekwall, E., Svensson, S. B.: Immunology and immunochemistry of synthetic and semisyntheticSalmonella O-antigen-specific glyco-conjugates. In:Anderson, L., Unger, F. (eds.) Bacterial Lipopolysaccharides: Structure, synthesis, biological activities. Am. Chem. Soc. Symp. Series 231, 1983, Washington D. C., pp. 195–218.Google Scholar
  19. 19.
    van Dijk, W. C., Verbrug, H. A., van Erne-van der Tol, M. E., Peters, R., Verhoef, J. Escherichia coli antibodies in opsonisation and protection against infection. J. Med. Microbiol. 14 (1981) 381–389.Google Scholar
  20. 20.
    Lindberg, A. A., Greisman, S. E., Svensson, S. B. Induction of endotoxin tolerance with nonpyrogenic O-antigenic oligosaccharideprotein conjugates. Infect. Immun. 41 (1983) 888–895.Google Scholar
  21. 21.
    Johnston, C. A., Greisman, S. E. Mechanisms of endotoxin tolerance. In:Proctor, R. A. (ed.): Handbook of endotoxin, Vol. 2,Hinshaw, L. B. (ed.): Pathophysiology of endotoxin. Elsevier, Amsterdam, New York, Oxford 1985, pp. 359–401.Google Scholar
  22. 22.
    Collins, M. S., Roby, R. E. Protective activity of an intravenous immunoglobulin (human) enriched in antibody against lipopolysaccharide antigens ofPseudomonas aeruginosa. Am. J. Med. 76 (1984) 168–176.Google Scholar
  23. 23.
    Gaffin, S. L. Gram-negative bacteraemia: New therapeutic possibilities with anti-endotoxin antibodies. Haemet. Blood Trans. 29 (1985) 107–111.Google Scholar
  24. 24.
    Pennington, J. E., Pier, C. B., Small, G. J. Efficacy of intravenous immunoglobulin for treatment of experimentalPseudomonas aeruginosa infection. J. Crit. Care 1 (1986) 4–12.Google Scholar
  25. 25.
    Brade, L., Kosma, P., Appelmelk, B. J., Paulsen, H., Brade, H.: Determination of the epitope specificity of monoclonal antibodies against the 3-deoxy-D-manno-2-octulosonate region of bacterial lipopolysaccharide by use of synthetic antigens. Infect. Immun. 1986 (im Druck).Google Scholar
  26. 26.
    Ziegler, E. J., Douglas, H., Sherman, J. E., Davis, C. E., Braude, A. I. Treatment ofE. coli andKlebsiella bacteremia in agranulocytic animals with antiserum to a UDP-GAL epimerase-deficient mutant. J. Immunol. 111 (1973) 433–438.Google Scholar
  27. 27.
    Johns, M., Skehill, A., McCabe, W. R. Immunization with rough mutants ofSalmonella minnesota IV. Protection by antisera to O and rough antigens against endotoxin. J. Inf. Dis. 147 (1983) 57–67.Google Scholar
  28. 28.
    Trautmann, M., Hahn, H. Antiserum againstEscherichia coli J5: A reevaluation of itsin vitro andin vivo activity against heterologous gram-negative bacteria. Infection 13 (1985) 140–145.Google Scholar
  29. 29.
    Siber, G. R., Kania, S. A., Warren, H. S. Cross-reactivity of rabbit antibodies to lipopolysaccharides ofEscherichia coli J5 and other gram-negative bacteria. J. Infect. Dis. 152 (1985) 954–964.Google Scholar
  30. 30.
    Brade, H., Galanos, C. Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysacharides from different families of gram-negative bacteria. Infect. Immun. 42 (1983) 250–256.Google Scholar
  31. 31.
    Brade, L., Brade, H. A 28,000 Dalton protein of normal mouse serum binds specifically to the inner core region of bacterial lipopolysaccharide. Infect. Immun. 50 (1985) 687–694.Google Scholar
  32. 32.
    Kim, Y. B., Watson, D. W. Modification of host response to bacterial endotoxins. II. Passive transfer of immunity to bacterial endotoxin with fractions containing 19S antibodies. J. Exp. Med. 121 (1965) 751–759.Google Scholar
  33. 33.
    Galanos, C., Lüderitz, O., Westphal, O. Preparation and properties of antisera against the lipid A component of bacterial lipopolysaccharides. Eur. J. Biochem. 24 (1971) 116–122.Google Scholar
  34. 34.
    Galanos, C., Freudenberg, M. A., Jay, F., Nerkar, D., Veleva, K., Brade, H., Strittmatter, W. Immunogenic properties of lipid A. Rev. Infect Dis. 5 (1984) 546–552.Google Scholar
  35. 35.
    Jirillo, E., Miragliotta, G., Galanos, C., Rietschel, E. Th., Michalek, S. M., McGhee, J. R. (eds.): Endotoxin: structural aspects and immunobiology of host responses. EOS - Riv. Immunol. Immunofarm. 6 Suppl. (1986) 1–275.Google Scholar
  36. 36.
    Marget, W., Mar, P. J., Jaspers, L. Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients. Infection 13 (1985) 120–125.Google Scholar
  37. 37.
    Brade, L., Brade, H. Characterization of two different antibodies recognizing two distinct antigenic determinants in free lipid A ofEscherichia coli. Infect. Immun. 48 (1985) 569–575.Google Scholar
  38. 38.
    Brade, L., Rietschel, E. Th., Kusumoto, S., Shiba, T., Brade, H. Immunogenicity and antigenicity of syntheticEscherichia coli lipid A. Infect. Immun. 51 (1986) 110–114.Google Scholar
  39. 39.
    Kusumoto, S., Yoshimura, H., Imoto, M., Shimamoto, T., Shiba, T. Chemical synthesis of 1-dephospho derivatives ofEscherichia coli lipid A. Tetrahedron Lett. 26 (1985) 909–912.Google Scholar
  40. 40.
    Galanos, C., Lehmann, V., Lüderitz, O., Rietschel, E. Th., Westphal, O., Brade, H., Brade, L., Freudenberg, M. A., Hansen-Hagge, T., Lüderitz, Th., McKenzie, G., Schade, U., Strittmatter, W., Tanamoto, K., Zähringer, U., Imoto, M., Yoshimura, H., Yamamoto, M., Shimamoto, T., Kusumoto, S., Shiba, T. Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur. J. Biochem. 140 (1984) 221–227.Google Scholar
  41. 41.
    Brade, L., Rietschel, E. Th., Kusumoto, S., Shiba, T., Brade, H. Immunogenicity and antigenicity of natural and syntheticEscherichia coli lipid A and derivatives thereof. In:Watson, S. W. (ed.): 2nd International Conference on Endotoxins and Their Detection with theLimulus amebocyte lysate test. Alan R. Liss Inc., New York 1986 (im Druck).Google Scholar
  42. 42.
    Freudenberg, M. A., Keppler, D., Galanos, C. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization of endotoxin. Infect. Immun. 51 (1986) 891–895.Google Scholar
  43. 43.
    Schade, U., Rietschel, E. Th. The role of prostaglandins in endotoxic activities. Klin. Wochenschr. 60 (1982) 743–745.Google Scholar
  44. 44.
    Hagman, W., Denzlinger, C., Keppler, D. Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action. Circ. Shock 14 (1984) 223–235.Google Scholar
  45. 45.
    Lüderitz, Th., Schade, U., Rietschel, E. Th. Formation and metabolism of leukotriene C4 in macrophages exposed to bacterial lipopolysaccharide. Eur. J. Biochem. 155 (1986) 377–382.Google Scholar
  46. 46.
    Beutler, B., Milsark, I. W., Cerami, A. C. Passive immunization against cachectin/tumour necrosis factor protects mice from lethal effect of endotoxin. Science 229 (1985) 869–871.Google Scholar
  47. 47.
    Freudenberg, M., Galanos, C. Alteration in ratsin vivo of the chemical structure of lipopolysaccharides fromSalmonella abortus equi. Eur. J. Biochem. 152 (1985) 353–359.Google Scholar
  48. 48.
    Munford, R. S. Deacylation of bacterial endotoxins by neutrophils and macrophages: early observations and hypotheses. Meth. and Find. Exptl. Clin. Pharmacol. 8 (1986) 63–65.Google Scholar
  49. 49.
    Ray, P. H., Kelsey, J. E., Bigham, E. C., Benedict, C. D., Miller, T. A.: Synthesis and use of 3-deoxy-D-manno-2-octulosonate (KDO) inEscherichia coli. Potential sites of inhibition. In:Anderson, L., Unger, F. M. (eds.) Bacterial Lipopolysaccharides: Structure, synthesis and biological activities. Am. Chem. Soc. Symp. Series 231 (1983) Washington, D. C., pp. 141–169.Google Scholar

Copyright information

© MMV Medizin Verlag GmbH München 1987

Authors and Affiliations

  • E. Th. Rietschel
    • 1
  • H. Brade
    • 1
  1. 1.Forschungsinstitut BorstelInstitut für Experimentelle Biologie und MedizinBorstel

Personalised recommendations